1 / 34

Experiences of Children Enrolled in Pediatric Oncology Research: Implications for Assent

Experiences of Children Enrolled in Pediatric Oncology Research: Implications for Assent. Yoram Unguru, MD, MS, MA The Herman & Walter Samuelson Children’s Hospital at Sinai Division of Pediatric Hematology/Oncology Johns Hopkins University - Berman Institute of Bioethics. DISCLOSURES. None.

helga
Download Presentation

Experiences of Children Enrolled in Pediatric Oncology Research: Implications for Assent

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Experiences of Children Enrolled in Pediatric Oncology Research: Implications for Assent Yoram Unguru, MD, MS, MA The Herman & Walter Samuelson Children’s Hospital at Sinai Division of Pediatric Hematology/Oncology Johns Hopkins University - Berman Institute of Bioethics

  2. DISCLOSURES • None

  3. "The good parent does not just nurture to a point of maturation: he is expected to inhibit self-destructive impulses; he is expected to substitute his superior judgment for the short vision of the child; he is expected to use education, persuasion, seduction, and even force and coercion when necessary in the service of producing a healthy and independent adult." Gaylin W. Competence: No longer all or none.  In: Gaylin W and Macklin R eds. Who speaks for the Child: The problems of proxy consent. New York: Plenum Press; 1982, 31.

  4. BACKGROUND • Research is a cornerstone of modern medicine • Research agenda is the sine qua non of pediatric cancer • Cancer clinical research trials • Children >>>>> Adults

  5. BACKGROUND • Pediatric clinical trials are complex * • Therapeutic misconception

  6. WHY IS ASSENT AN IMPORTANT TOPIC? • Birth of assent • History of assent • National Commission + Belmont Report • American Academy of Pediatrics

  7. BELMONT • “Because the subject's ability to understand is a function of intelligence, rationality, maturity and language, it is necessary to adapt the presentation of the information to the subject's capacities.” • “Investigators are responsible for ascertaining that the subject has comprehended the information.” • National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Government Printing Office.

  8. AAP • “[Make] a clinical assessment of [the] patient’s understanding of the situation and the factors influencing how he or she is responding, including whether there is inappropriate pressure to accept testing or therapy.” • Committee on Bioethics, American Academy of Pediatrics. Informed consent, parental permission, and assent in pediatric practice. Pediatrics 1995;95:314-317.

  9. BACKGROUND • Subpart D of 45 CFR 46 governs pediatric research (1983) • Assent • “A child’s affirmative agreement to participate in research. Mere failure to object should not, absent affirmative agreement, be construed as assent” • IRBs • “shall determine that adequate provisions are made for soliciting the assent of the children, when in the judgment of the IRB the children are capable of providing assent”

  10. PROBLEMS • Vague and unclear • Problems with CFR definition of assent • No specific age limit • Onus is on IRB • Flexible, yet fail to enumerate what is required with too little guidance as to what constitutes a meaningful concept of assent • Kimberely, et al. Variation in Standards of Research Compensation and Child Assent Practices: A Comparison of 69 Institutional Review Board-Approved Informed Permission and Assent Forms for 3 Multicenter Pediatric Clinical Trials. Pediatrics 2006;117:1706-1711. • Whittle, et al. Institutional Review Board Practices Regarding Assent in Pediatric Research. Pediatrics 2004;113:1747-1752.

  11. MORE PROBLEMS • Assent in 2009 • No consensus • Government, Prof associations, Assent community • Definition • Age • Participants • Conflict resolution • Assent vs consent • Disclosure • Children’s desires • Assessment • Decision-making model

  12. ASSENT  CONSENT • Children’s Views on Their Involvement in Clinical Research • Chappuy H, et al. Ped Blood & Cancer 2008;50:1043-1046 • “To examine the level of children’s understanding of informed consent in clinical trials & factors that may influence these processes” • “Determine children’s understanding of 9 items required in the informed consent document”*

  13. ASSENT IN 2009 ASSENT IN 2007

  14. BACKGROUND • Components of valid assent • Determine children’s understanding • Preferences for involvement • Children & the therapeutic misconception

  15. METHODS • Sample • 7-18 year olds with cancer who have assented to therapeutic clinical trials • Survey instrument (QuAs) • Closed-ended • Open-ended

  16. METHODS • Eligibility criteria • Sixty-two children • Documented malignancy • Age 7-18 years • Assented to a COG / PBTC research protocol

  17. METHODS • Study Procedure • Semi-structured, private, face-to-face, audio-recorded interviews • Respondents were given a questionnaire identical to the one used by the investigator • Questions were read aloud & children responded orally • Prompts were included to assure understanding • Interviews were transcribed verbatim & verified against the audiotape

  18. Research Familiarity Knowledge Awareness Understanding Appreciation Decision-making Decisional priority Types of decisions Role in decision to enroll Preferences / Perceptions Suggestions CHILDREN’S UNDERSTANDING & PREFERENCES for RESEARCH INVOLVEMENT

  19. FAMILIARITY & KNOWLEDGE of RESEARCH • Research term • Study • Research • Protocol • Experimental • Trial • Enrollment • Randomization • Consent • Assent • Knowledge of research • Familiarity + being told about different ways to tx illness

  20. AWARENESS of RESEARCH • Know tx is considered clinical research • Main reason for study participation is to improve care for future children with cancer • One reason for study participation is to determine effect(s) of tx(s) • Prior to starting tx, signed name to a form • Know that signing name means agreed to participate in a study • Read form • Child / Parent received copy of signed form

  21. UNDERSTANDING of RESEARCH • One reason my doctor is giving me the medicines (s)he is, is to compare (figure out) the effects (good & bad) of 2 or more different ways of treating other children who have the same type of illness as mine to see which is better • The treatment I get/got as part of the clinical research was chosen randomly (by chance, like flipping a coin) from 2 or more options • Compared to other treatment for my illness, my study does not have more risks or discomforts (bad things) associated with it • It is proven that the medicines I am getting are the best treatment for my type of illness • By being part of the study, I am helping my doctor learn about my illness & ways to help kids who will get sick like me in the future • I can withdraw (not be part of) from the study anytime my parents or I decide to withdraw

  22. APPRECIATION of RESEARCH • Why did you decide to participate in a clinical research study? • My parents told me to • My doctor told me to • My parents & doctor told me to • To get better • To help other children • To help my doctor learn more about illness

  23. DECISION-MAKING • Decisional priority • Children’s overall involvement in decisions • Types of decisions • Major or minor • Role in decision to enroll • Very large, Large, Little, Very little, None • Preferences / Perceptions • Info, peer discussions, inclusion in decisions • Suggestions • For improving their role in decision-making

  24. RESULTS • Children • Unaware their treatment is clinical research • Limited understanding of research * • Do not understand MD’s explanation * • Personal gain + Altruism * • Pressured to enroll * • Exclusion versus inclusion * • Reluctant to discuss decision-making * • Types of decisions – Minor • Want to make decisions • Desire parental + MD role * • Interested in research

  25. Children’s Familiarity with Research Terminology,Research Knowledge, & Elements Comprising Awareness of Research Enrollment (n = 37)

  26. RESULTS • HD & GCT greater knowledge (mean=7.6) than “others” (mean=5.0) • HD, CNS, leukemia higher mean understanding (7.8, 7.5, 6.8) than “others” (mean 6.0) • Controlling for age, neither remained sig, p=0.38, p=0.22 • Knowledge, awareness, understanding, & appreciation of research were not significantly associated with gender, protocol phase or type, months since diagnosis, or ongoing versus completed treatment • HD, GCT, leukemia significantly greater awareness(mean=5.5) & appreciation (mean=2.2) than “others” (mean 3.6 & 1.0) • Remained significant when controlling for age, p=0.019, p<0.001

  27. CHILDREN’S SUGGESTIONS for IMPROVEMENT • “Talk to me (too)” • No “medicalese” • “Don’t assume” • Be honest / truthful • More choices / details • “Don’t focus on my age” • Offer advice

  28. DISCUSSION • Irrespective of age, children with HD, GCT, & leukemia had sig greater awareness & appreciation of research (p=0.019, p<0.001) • ?Outcome-related • ?Altruism • Decisional priority + Pressure to enroll

  29. LIMITATIONS • Single investigator-single institution, pilot study • Responses may not reflect actual beliefs, but what children think investigators want them to say • Interviews occurred after children had assented to research enrollment • Findings reflect reports of children only

  30. IMPLICATIONS • Clinical trials • Gold standard in pediatric heme/onc • Improve understanding • Greater decision-making role • When appropriate

  31. Present me with more choices for treatment in the • beginning. [Things like] Facts & previous outcomes from • treatments they've given. I know decisions sometimes are • needed in a short amount of time, but sometimes you need a • little time to think about what's going to happen - at least • just ask. Just because I am deemed a child because I'm less • than 18, I don't think I should be treated like a full child • when it comes to my health . . . I need doctors' advice, but • sometimes I want to decide & not be written off & treated • like a child because I'm under 18 • 17 year-old

  32. LET ASSENT OUT ITS CAGE

More Related